JONATHAN LURZ: Open Payments
NPI 1619599958 · CLAREMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 62 payments from 13 companies in 2025. Trend: 2023 $1,764 · 2024 $1,877 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $309 |
| Otsuka America Pharmaceutical, Inc. | 7 | $230 |
| Collegium Pharmaceutical, Inc. | 3 | $154 |
| Vanda Pharmaceuticals Inc. | 11 | $139 |
| Alkermes, Inc. | 7 | $133 |
| E.R. Squibb & Sons, L.L.C. | 6 | $123 |
| ABBVIE INC. | 6 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 1 | $81 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
Products named: Auvelity, REXULTI, Jornay PM, FANAPT, ARISTADA, COBENFY, VRAYLAR, CAPLYTA.
Industry payments across OK — which companies pay providers there.
